Qualifying Digital Biomarkers ‘Much Easier Now’ Thanks To EMA Efforts

 
• By Vibha Sharma

The European Medicines Agency has been on a steep learning curve with its qualification of a digitally-measured outcome for use in Duchenne muscular dystrophy trials, smoothing the way for other developers entering the digital biomarker space.

Medicine doctor hands with digital medical interface icons on blur background, Medical technology and healthcare smart watch concept.
Digital endpoints are clinical outcomes gathered outside of the clinical setting, usually through devices like wearable sensors • Source: Shutterstock

More from Europe

More from Geography